ロード中...
Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer
Background/Aim: Published data have shown that palbociclib-fulvestrant can significantly improve the progression-free survival (PFS) of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) metastatic breast cancer patients, but not of Japanese patients. We conduct...
保存先:
| 出版年: | In Vivo |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Institute of Anticancer Research
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899113/ https://ncbi.nlm.nih.gov/pubmed/31662535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11701 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|